| Literature DB >> 32452217 |
Niloufar Maghsoudnia1, Reza Baradaran Eftekhari1, Alireza Naderi Sohi2, Parisa Norouzi1, Hamid Akbari1, Mohammad Hossein Ghahremani3, Masoud Soleimani4, Mohsen Amini5, Hamed Samadi6, Farid Abedin Dorkoosh1,7.
Abstract
Many biological mechanisms including cellular metabolism and cell death are regulated by mitochondria known as powerhouse of the cell. Recently, let-7b, a tumour-suppressor microRNA has been detected in mitochondria of human cells targeting several mitochondrial-encoded respiratory chain genes. Triphenylphosphonium cation (TPP) is one of the major classes of mitochondriotropics that possess the ability of specifically targeting the mitochondria. PAMAM dendrimers are one of the most available agents in gene delivery due to their well-defined and beneficial features such as large density of surface functional groups. Hyaluronic acid (HA), a natural polysaccharide has been demonstrated to have the abilities such as good biocompatibility and targeting CD44 overexpressed receptors on non-small cell lung cancer (NSCLC) cells. In this research, let-7b-PAMAM (G5)-TPP and let-7b-PAMAM (G5)-TPP-HA nano-carriers were designed to deliver let-7b miRNA mimic to NSCLC cells' mitochondria as a novel way of cancer cells inhibition. Nano-carriers were capable of being successfully taken up by A549 cells and localised in mitochondria environment. Let-7b loaded nanoparticles reduced cell viability and induced apoptosis significantly. Expression of genes involved in mitochondrial oxidative function was decreased resulting in nanoparticles effect on mitochondria. Application of mitochondria targeted-miRNA delivery systems could regulate cellular functions to inhibit lung cancer.Entities:
Keywords: PAMAM (G5) dendrimers; hyaluronic acid; microRNA let-7b; mitochondria; triphenylphosphonium
Year: 2020 PMID: 32452217 DOI: 10.1080/1061186X.2020.1774594
Source DB: PubMed Journal: J Drug Target ISSN: 1026-7158 Impact factor: 5.121